Article metrics

Download PDFPDF
CP-134 Analysys of therapeutic response and tolerability in patients treated with crizotinib in ALK positive NSCLC

 

Online download statistics by month:

Online download statistics by month: February 2016 to March 2024

AbstractFullPdf
Feb 2016300
Apr 2016103
May 2016100
Jun 2016200
Jul 2016502
Aug 2016200
Sep 2016100
Oct 2016400
Nov 2016800
Dec 2016200
Jan 2017200
Feb 20171100
Mar 2017703
Apr 2017200
May 2017300
Jun 2017801
Jul 20172801
Aug 2017200
Sep 20171402
Oct 20171600
Nov 2017200
Dec 2017600
Jan 2018400
Feb 20181000
Mar 20181200
Apr 2018600
May 20181400
Jun 20182400
Jul 20181000
Aug 20181200
Sep 2018400
Oct 2018600
Nov 20181200
Dec 20181200
Jan 20191200
Feb 2019400
Mar 2019600
Apr 2019601
May 2019201
Jun 2019800
Jul 2019601
Aug 2019001
Sep 20191200
Oct 2019800
Nov 2019400
Dec 2019600
Jan 2020600
Feb 20201401
Mar 20201201
May 2020400
Jun 2020801
Jul 2020800
Aug 2020400
Sep 20203201
Oct 2020600
Dec 2020400
Jan 20211000
Mar 2021600
Apr 2021800
May 2021200
Jun 2021100
Nov 20211200
Dec 2021600
Jan 2022200
Feb 2022200
Mar 2022600
Apr 2022600
May 2022600
Jun 2022200
Jul 2022600
Aug 2022600
Sep 2022200
Oct 20221000
Nov 20221200
Dec 20221000
Jan 2023400
Feb 2023600
Mar 2023800
Apr 2023600
May 2023200
Jul 2023200
Sep 2023400
Oct 2023400
Nov 2023400
Dec 20232600
Jan 2024600
Feb 20244000
Mar 20241200
Total667020